Free nicotine patches and counseling offered by national smoking helpline don't help quitters

March 22, 2012 in Addiction

A major research trial to test the effectiveness of offering smokers free nicotine patches and proactive telephone counselling through the English national quitline has shown this extra support makes no difference to success rates for quitting the habit.

The Department of Health and UK Centre for Tobacco Control Studies (UKCTCS)-funded study led by The University of Nottingham's UK Centre for Studies has just been published in the online version of the .

The work was carried out to establish whether the tried and tested support from the quitline could be improved to help more people stop smoking. The trial also examined whether the offer of free nicotine replacement therapy made to quitline callers increases the numbers of smokers who give up for good.

Smoking remains the single most important avoidable cause of illness and death and research into is a top public health priority in the UK. This latest study by UKCTCS set out to compare the effectiveness of a package of extra support offered to smokers with the standard support offered through the English NHS Smoking Helpline.

Leading the study, Professor Tim Coleman of UKCTCS, said: "This important trial has shed useful light on how telephone quitlines can be used to help smokers wanting to quit. I think the results highlight just how hard it is for most people to break their to tobacco and just how powerful and damaging a drug this is. On the basis of this study, giving out free and more intensive telephone counselling through the English national quitline just doesn't seem to work. It brings into sharp relief the need to find other ways of using quitlines help smokers give up and so to reduce the terrible effects smoking has on people's lives and the costly burden to the NHS."

The researchers carried out a parallel four group (2x2), randomised among 2,591 non-pregnant smokers who called the English NHS smoking helpline between February 2009 and February 2010. Each smoker was randomly assigned to one of four groups:

  • Standard support— NHS Stop Smoking Services advice and access to helpline
  • Standard support with free (NRT)
  • Proactive support —consisting of extra and regular scheduled telephone and message support from helpline staff.
  • Proactive support with free (NRT)
The proactive groups were contacted by counsellors before their agreed quit date, on the day itself, and then at 3,7,14 and 21 days after quitting. Counsellors were trained to use specially designed motivational interviewing techniques which were tailored to each stage of the quitting process. The support closely monitored the two proactive groups' progress, and offered counselling, encouragement and congratulations.

Trial follow up was carried out by a market research company who were blind to treatment allocations. They collected data by telephone at one and six months after quit dates. The primary outcome was self-reported, prolonged abstinence from smoking from the quit date to six months. Lapses of no more than five cigarettes in that period were allowed. Prolonged abstinence from the quit date and one month was also monitored with the same lapses permitted.

Analysis of the substantial bank of data recorded during the trial showed that at six months after quitting 18.9 per cent of the 59 per cent of participants who were contacted said they had managed not to smoke. Those whom the researchers were not able to contact were assumed to be smoking. Nearly 80 per cent of these agreed to give a breath test for carbon monoxide to validate their claim and 80 per cent of the tests proved they had quit successfully. Crucially no significant difference in success rates was observed between quit rates in the standard and proactive counselling groups or between those offered and not offered, NRT.

At one month after quit date higher follow-up rates were achieved (65.3 per cent of participants were contacted) but even with more complete data and the higher overall quit rates at one month (40.1 per cent), no significant differences were detected between the different intervention groups.

Overall the study has concluded that offering free patches or proactive counselling to smokers calling the English national smoking quitline was no more effective than the standard reactive quitline support which is currently on offer through the NHS. Quitlines can reach large numbers of smokers who are highly motivated to stop . Consequently, future research needs to test other methods of providing cessation support to quitline callers so the most effective ways using quitlines can be discovered.

Provided by University of Nottingham search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Beer-industry advertising guidelines: Rating panels may help industry assess itself

In order to avoid exposing vulnerable groups such as children and young adults to alcohol advertising, industry groups have developed their own self-regulation guidelines. However, these guidelines have been criticized for ...

Addiction created May 17, 2013 | popularity not rated yet | comments 0

College women exceed NIAAA drinking guidelines more frequently than college men

In order to avoid harms associated with alcohol consumption, in 2009 the National Institute on Alcohol Abuse and Alcoholism issued guidelines that define low-risk drinking. These guidelines differ for men and women: no more ...

Addiction created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast

Individuals who drink heavily and smoke may show 'early aging' of the brain

Treatment for alcohol use disorders works best if the patient actively understands and incorporates the interventions provided in the clinic. Multiple factors can influence both the type and degree of neurocognitive abnormalities ...

Addiction created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast

Researchers analyze how Spanish smoking relapse booklets are distributed

Researchers from Moffitt Cancer Center and the University of South Florida have evaluated how Florida health care and social service agencies distribute "Libres para Siempre", a Spanish smoking relapse prevention booklet ...

Addiction created May 17, 2013 | popularity not rated yet | comments 0

No significant change seen in overall smokeless tobacco use among US youths

Tobacco use remains the leading preventable cause of death and disease in the United States. Declines in smoking among youths were observed from the late 1990s. "However, limited information exists on trends in smokeless ...

Addiction created May 14, 2013 | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.